GlassScriptPhysician profile
Mary Meux
NPI 1235208299
$379.83
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $36.39 · 2020: $34.50 · 2022: $167 · 2023: $110 · 2024: $32.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $125 · Education: $17.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $124.64 |
| Education | $17.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $80.61 | 2022-2023 | Vaxelis, Proquad, Gardasil 9 |
| Biohaven Pharmaceutical Holding Company LTD. | $75.53 | 2022 | |
| Indivior INC. | $37.01 | 2023 | Sublocade |
| Glaxosmithkline, LLC. | $36.39 | 2019 | |
| Sanofi Pasteur INC. | $34.50 | 2020 | |
| Pfizer INC. | $30.77 | 2023-2024 | |
| Organon LLC | $27.27 | 2022 | |
| Lilly USA, LLC | $15.29 | 2023 | Mounjaro |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.25 | 2023 | Xifaxan |
| Abbvie INC. | $14.61 | 2024 | |
| Xeris Pharmaceuticals, INC. | $12.60 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Meux listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.